Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03168191 · ClinicalTrials.gov registry record · Phase 1
Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT03168191: Completed Phase 1 study, sponsored by Yale University.
NCT03168191 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 56 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03168191, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
This study is to examine if inhaled doses of an e-cigarette flavor, alone and in combination with menthol, changes the appeal of e-cigarettes containing low and high doses of nicotine. The hypothesis is that menthol and the other experimental flavor will interact with nicotine dose to improve taste and liking for e-cigarettes.
Primary Outcome
The Drug Effects Questionnaire (Soria et al) will be used to ask about liking and wanting during the lab session
Interventions
- DRUG Nicotine
- OTHER Experimental Flavor
- OTHER Menthol Flavor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2017-05-02 |
| Est. Completion | 2019-02-25 |
| Phase | Phase 1 |
What the finished NCT03168191 record still lists
NCT03168191 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Nicotine is the first listed.
NCT03168191 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03168191 about?
NCT03168191 is a clinical study titled "Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2". This study is to examine if inhaled doses of an e-cigarette flavor, alone and in combination with menthol, changes the appeal of e-cigarettes containing low and high doses of nicotine. The hypothesis is that menthol and the other experimental flavor will interact with nicotine dose to improve taste ...
What is the current status of trial NCT03168191?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2017-05-02. Estimated completion is 2019-02-25.
What interventions are being tested in trial NCT03168191?
The interventions under investigation include: Nicotine (DRUG), Experimental Flavor (OTHER), Menthol Flavor (OTHER).
Who is sponsoring clinical trial NCT03168191?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03168191's enrollment target sits among peer trials
56 902nd of 2000 higher than 1,083 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI